Protalix Biotherapeutics, Inc. (PLX)
2.14
-0.09
(-4.04%)
USD |
NYAM |
Mar 20, 16:00
2.14
0.00 (0.00%)
After-Hours: 20:00
Protalix Biotherapeutics Research and Development Expense (Quarterly) : 5.635M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Denali Therapeutics, Inc. | 97.90M |
| Agenus, Inc. | 7.511M |
| Lisata Therapeutics, Inc. | 1.134M |
| InspireMD, Inc. | 3.475M |
| Lifeward Ltd. | 0.843M |